Literature DB >> 30876777

Intradermal mesotherapy versus systemic therapy in the treatment of musculoskeletal pain: A prospective randomized study.

Abdullah Osman Kocak1.   

Abstract

INTRODUCTION: Acute musculoskeletal injuries are one of the most common painful presentation when admission to the emergency department. The aim of the study is to compare the tenoxicam mesotherapy with intravenous dexketoprofen in pain control in patients with acute musculoskeletal injury.
METHODS: This parallel randomized controlled trial was conducted with the patients admitted to the emergency department with musculoskeletal injury. Intravenous dexketoprofen was administered to the control group, and mesotherapy treatment was performed to the other group. Differences between 10th, 30th, 60th and 120th minutes VAS scores and on the admission VAS score, clinically meaningful change in pain intensity, and adverse effect of the procedures were compared among groups. THE
RESULTS: The differences in VAS scores and the presence of clinically meaningful change in pain intensity were statistically significantly higher in mesotherapy group than the systemic therapy group in all time periods. During one-week follow-up period, there was no reported adverse effect neither in mesotherapy group nor in the systemic therapy group.
CONCLUSIONS: The mesotherapy treatment may be superior than the systemic therapy for pain relief in musculoskeletal injury in short term follow-up in emergency department settings.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute pain; Mesotherapy; Musculoskeletal pain; Nonsteroidal anti-inflammatory drug

Year:  2019        PMID: 30876777     DOI: 10.1016/j.ajem.2019.02.042

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Comparison of intravenous ibuprofen and tenoxicam efficiency in ankle injury: a randomized, double-blind study.

Authors:  Gonca Koksaldi Sahin; Muge Gulen; Selen Acehan; Deniz Aka Satar; Tahsin Erfen; Salim Satar
Journal:  Ir J Med Sci       Date:  2022-09-13       Impact factor: 2.089

2.  Multiple session mesotherapy for management of coxofemoral osteoarthritis pain in 10 working dogs: A case series.

Authors:  João C Alves; Ana Santos; Patrícia Jorge; Pilar Lafuente
Journal:  Can Vet J       Date:  2022-06       Impact factor: 1.075

3.  Intradermal mesotherapy versus intravenous dexketoprofen for the treatment of migraine headache without aura: a randomized controlled trial.

Authors:  Ilker Akbas; Meryem Betos Kocak; Abdullah Osman Kocak; Sultan Tuna Akgol Gur; Sinem Dogruyol; Mehmet Demir; Zeynep Cakir
Journal:  Ann Saudi Med       Date:  2021-06-01       Impact factor: 1.526

Review 4.  Mesotherapy: From Historical Notes to Scientific Evidence and Future Prospects.

Authors:  Massimo Mammucari; Enrica Maggiori; Domenico Russo; Chiara Giorgio; Gianpaolo Ronconi; Paola E Ferrara; Flora Canzona; Luciano Antonaci; Bartolomeo Violo; Renato Vellucci; Domenico Rocco Mediati; Alberto Migliore; Umberto Massafra; Barbara Bifarini; Fabio Gori; Massimo di Carlo; Stefano Brauneis; Teresa Paolucci; Piergiovanni Rocchi; Anna Cuguttu; Raffaele Di Marzo; Alessandro Bomprezzi; Stefania Santini; Manuela Giardini; Anna Rosa Catizzone; Fiammetta Troili; Dario Dorato; Alessandra Gallo; Costanza Guglielmo; Silvia Natoli
Journal:  ScientificWorldJournal       Date:  2020-05-01

Review 5.  A Call to Action by the Italian Mesotherapy Society on Scientific Research.

Authors:  Massimo Mammucari; Teresa Paolucci; Domenico Russo; Enrica Maggiori; Raffaele Di Marzo; Alberto Migliore; Umberto Massafra; Gianpaolo Ronconi; Paola Emilia Ferrara; Fabio Gori; Barbara Bifarini; Stefano Brauneis; Renato Vellucci; Rocco Domenico Mediati; Bartolomeo Violo; Silvia Natoli; Carmen Pediliggieri; Cristiana Di Campli; Maria Chiara Collina
Journal:  Drug Des Devel Ther       Date:  2021-07-12       Impact factor: 4.162

6.  Safety and efficacy of mesotherapy in musculoskeletal disorders: A systematic review of randomized controlled trials with meta-analysis.

Authors:  Lorenzo Faetani; Daniele Ghizzoni; Antonio Ammendolia; Cosimo Costantino
Journal:  J Rehabil Med       Date:  2021-04-27       Impact factor: 2.912

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.